How Cross-Training and Extreme Ownership Help You Advance Your Career with Rollie Carlson

Mastering Medical Device

Send us a text

Rollie Calrson is the CEO of Immunexpress, a company that is pioneering technology that can rapidly detect sepsis. Rollie contributed to the success of Abbott Laboratories for 20 years, starting off in R&D, then transitioning to leadership positions in global businesses and start-up ventures. His attraction to start-ups led him to become CEO of Asuragen and then WaferGen Biosystems. In this episode we discuss how he prepared for new opportunities, the benefits of extreme ownership, balancing company vision and mission, alignment of everyone in a company, why sepsis is such a big problem, and what Immunexpress is doing to help clinicians better manage sepsis patients.  

Links from this episode:

  • Rollie Carlson LinkedIn https://www.linkedin.com/in/rollie-carlson-ph-d-059074a/
  • Immunexpress  https://immunexpress.com/

Support the show

Connect with Mastering Medical Device:

  • Website: https://www.masteringmedicaldevice.com
  • LinkedIn: https://www.linkedin.com/company/mastering-medical-device
  • Patrick Kothe LinkedIn: https://www.linkedin.com/in/patrick-kothe
  • Patrick Kothe Twitter: https://twitter.com/patrickkothe

Support the show for as little as $3/month: https://www.buzzsprout.com/1286645/support

Thanks for listening!

Melde dich an, um anstößige Folgen anzuhören.

Bleib auf dem Laufenden mit dieser Sendung

Melde dich an oder registriere dich, um Sendungen zu folgen, Folgen zu sichern und die neusten Updates zu erhalten.

Wähle ein Land oder eine Region aus

Afrika, Naher Osten und Indien

Asien/Pazifik

Europa

Lateinamerika und Karibik

USA und Kanada